FDA 483 - Eckert & Ziegler Radiopharma GmbH - August 19, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Eckert & Ziegler Radiopharma GmbH, a manufacturer of radiopharmaceutical APIs in Berlin, Germany, was cited for significant deficiencies in environmental control, monitoring, and data integrity during an FDA inspection. Observations included inadequate smoke studies, lack of particle monitoring, unvalidated disinfectant efficacy, and issues with software audit trails and investigation practices. The findings indicate a need for improved aseptic processing controls and quality system oversight.
ID · 8349eeda-44e1-48d5-9b05-9fdab10fd2d8